[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:secondary-immune-deficiency-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":23,"states":24},"Secondary immune deficiency disorder",2,1,[8,16],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06980480","A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma",[12],"Phase 3","RECRUITING","2026-08-03T00:59:44.985880Z","2026-07-19T19:36:05.061485Z",{"nct_id":17,"title":18,"phases":19,"status":20,"updated_at":21,"content_modified":22},"NCT07648264","Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies",[12],"NOT_YET_RECRUITING","2026-08-03T01:02:24.524649Z","2026-07-24T01:27:14.908698Z",[],[]]